Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000527012 | SCV000658711 | benign | LAMA2-related muscular dystrophy | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764629 | SCV000895737 | uncertain significance | Merosin deficient congenital muscular dystrophy; Muscular dystrophy, limb-girdle, autosomal recessive 23 | 2022-04-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002526747 | SCV003527654 | uncertain significance | Inborn genetic diseases | 2021-07-15 | criteria provided, single submitter | clinical testing | The c.5405G>T (p.R1802L) alteration is located in exon 37 (coding exon 37) of the LAMA2 gene. This alteration results from a G to T substitution at nucleotide position 5405, causing the arginine (R) at amino acid position 1802 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003133364 | SCV003816357 | uncertain significance | not provided | 2022-01-27 | criteria provided, single submitter | clinical testing |